ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $895,000 | -57.5% | 248,600 | -61.6% | 0.06% | -48.2% |
| Q1 2017 | $2,107,000 | +8.5% | 648,200 | -18.2% | 0.11% | +0.9% |
| Q4 2016 | $1,942,000 | -35.7% | 792,617 | -9.8% | 0.11% | 0.0% |
| Q3 2016 | $3,022,000 | -26.2% | 878,531 | -25.3% | 0.11% | -47.2% |
| Q2 2016 | $4,093,000 | -17.2% | 1,176,031 | -1.8% | 0.21% | -13.4% |
| Q1 2016 | $4,945,000 | +11.1% | 1,197,338 | +19.7% | 0.25% | +0.8% |
| Q4 2015 | $4,450,000 | +0.8% | 1,000,000 | +37.9% | 0.24% | +34.6% |
| Q3 2015 | $4,415,000 | – | 725,007 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |